Ionox 330

CAS No. 1709-70-2

Ionox 330( Ahydol | Antioxidant 330 | Antioxidant 40 | AO-40 | BRN 2034522 )

Catalog No. M27111 CAS No. 1709-70-2

Ionox 330 is an alkylphenol compound used as an antioxidant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG 642 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ionox 330
  • Note
    Research use only, not for human use.
  • Brief Description
    Ionox 330 is an alkylphenol compound used as an antioxidant.
  • Description
    Ionox 330 is an alkylphenol compound used as an antioxidant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Ahydol | Antioxidant 330 | Antioxidant 40 | AO-40 | BRN 2034522
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1709-70-2
  • Formula Weight
    775.215
  • Molecular Formula
    C54H78O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1c(Cc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)c(C)c(Cc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)c(C)c1Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mofeed J, Mosleh YY. Toxic responses and antioxidative enzymes activity of Scenedesmus obliquus exposed to fenhexamid and atrazine, alone and in mixture. Ecotoxicol Environ Saf. 2013 Sep;95:234-40.
molnova catalog
related products
  • AUNP-12 TFA (1353563...

    AUNP-12 TFA (NP-12 TFA) is a polypeptide antagonist in the pd-1 signaling pathway, which has the same antagonistic effect on pd-l1 and pd-l2, and can protect the proliferation and effector function of lymphocytes.

  • fulvotomentoside A

    Fulvotomentoside A could decrease overexpression of IL-6 and IL-17A, and increase the expression of specific transcription factor Foxp3 of regulatory T cells significantly in intestine.

  • Mezagitamab

    Mezagitamab (TAK-079) is a fully humanized IgG1λ monoclonal antibody against CD38 with high affinity for CD38-expressing cells (including plasma mother cells, plasma cells, and natural killer cells).